ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
0,00%
S&P 500
5.222,68
0,00%
US Dollar vs BRL
5,1419
-0,09%
Bitcoin
62.743,79
2,11%
Brent Oil
83,13
0,90%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aethlon Medical Inc (AEMD)

  7. Aethlon Medical Inc (AEMD) Notícias

AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEMD
DataHoraFonteTítuloCódigoCompanhia
10/05/202409:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
10/05/202409:01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
21/02/202410:01PR Newswire (US)Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesNASDAQ:AEMDAethlon Medical Inc
14/02/202419:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
14/02/202418:15PR Newswire (US)Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
07/02/202410:00PR Newswire (US)Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024NASDAQ:AEMDAethlon Medical Inc
02/01/202420:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
22/12/202318:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AEMDAethlon Medical Inc
14/11/202318:15PR Newswire (US)Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
13/11/202310:01PR Newswire (US)Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating OfficerNASDAQ:AEMDAethlon Medical Inc
06/11/202310:01PR Newswire (US)Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023NASDAQ:AEMDAethlon Medical Inc
10/10/202309:01PR Newswire (US)Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in OncologyNASDAQ:AEMDAethlon Medical Inc
04/10/202309:01PR Newswire (US)Aethlon Announces Reverse Stock SplitNASDAQ:AEMDAethlon Medical Inc
30/08/202309:01PR Newswire (US)Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AEMDAethlon Medical Inc
10/08/202317:15PR Newswire (US)Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
03/08/202309:01PR Newswire (US)Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023NASDAQ:AEMDAethlon Medical Inc
27/07/202317:19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AEMDAethlon Medical Inc
27/07/202317:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AEMDAethlon Medical Inc
24/07/202309:01PR Newswire (US)Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for TransplantNASDAQ:AEMDAethlon Medical Inc
17/07/202317:43Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AEMDAethlon Medical Inc
06/07/202318:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
06/07/202315:17PR Newswire (US)Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of DirectorsNASDAQ:AEMDAethlon Medical Inc
28/06/202318:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AEMDAethlon Medical Inc
28/06/202318:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AEMDAethlon Medical Inc
28/06/202317:15PR Newswire (US)Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
22/06/202309:01PR Newswire (US)Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023NASDAQ:AEMDAethlon Medical Inc
21/06/202309:01PR Newswire (US)Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ TransplantationNASDAQ:AEMDAethlon Medical Inc
14/06/202309:01PR Newswire (US)Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-VestNASDAQ:AEMDAethlon Medical Inc
01/06/202316:51PR Newswire (US)Aethlon Medical to Present at the 13th Annual LD Micro InvitationalNASDAQ:AEMDAethlon Medical Inc
22/05/202309:01PR Newswire (US)Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in IndiaNASDAQ:AEMDAethlon Medical Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEMD

Seu Histórico Recente

GATE
FSTUSDT
Futureswap Token
USOTC
DGGRY
Dongguan Rural Commercia... (PK)
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados